Search by Drug Name or NDC

    NDC 75834-0170-01 NIVAGEN ZINC OXIDE 200 mg/g Details

    NIVAGEN ZINC OXIDE 200 mg/g

    NIVAGEN ZINC OXIDE is a TOPICAL OINTMENT in the HUMAN OTC DRUG category. It is labeled and distributed by Nivagen Pharmaceuticals, Inc.. The primary component is ZINC OXIDE.

    Product Information

    NDC 75834-0170
    Product ID 75834-170_c0fffe6a-f964-4a71-aac8-ca5d675e2168
    Associated GPIs 90971020004210
    GCN Sequence Number 005576
    GCN Sequence Number Description zinc oxide OINT. (G) 20 % TOPICAL
    HIC3 L3A
    HIC3 Description PROTECTIVES
    GCN 22080
    HICL Sequence Number 002361
    HICL Sequence Number Description ZINC OXIDE
    Brand/Generic Generic
    Proprietary Name NIVAGEN ZINC OXIDE
    Proprietary Name Suffix n/a
    Non-Proprietary Name ZINC OXIDE
    Product Type HUMAN OTC DRUG
    Dosage Form OINTMENT
    Route TOPICAL
    Active Ingredient Strength 200
    Active Ingredient Units mg/g
    Substance Name ZINC OXIDE
    Labeler Name Nivagen Pharmaceuticals, Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part347
    Listing Certified Through 2024-12-31

    Package

    NDC 75834-0170-01 (75834017001)

    NDC Package Code 75834-170-01
    Billing NDC 75834017001
    Package 28.4 g in 1 TUBE (75834-170-01)
    Marketing Start Date 2018-05-10
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.14655
    Pricing Unit GM
    Effective Date 2023-12-20
    NDC Description ZINC OXIDE 20% OINTMENT
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 4, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL 7b42655b-2163-4637-9f5d-1d2efa1bdf1d Details

    Revised: 2/2022